Overview

Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

Status:
Recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
to evaluate the efficacy and safety of CKD-828, D326, and D337 combination therapy in Hypertensive patients with Dyslipidemia
Phase:
Phase 3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical